James J. Donohue
CIK: 0001869107
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACXP
Acurx Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Donohue James J.
Donohue James J. (SEC CIK 0001869107) files insider reports with the SEC as Director of Acurx Pharmaceuticals, Inc. (ACXP).
Signal8 holds 2 ownership filings by Donohue James J., all Form 4s, filed between Jan 8, 2025 and Apr 22, 2026. Those filings report 2 transactions, from Jan 6, 2025 to Apr 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Donohue James J.'s filings is in STATEN ISLAND, NY.
Recent filings by Donohue James J.
Other insiders filing for Acurx Pharmaceuticals, Inc. (ACXP)
- Sailer Carl, Director
- DEAN JACK H, Director
- HARRISON THOMAS L, Director
- Scodari Joseph C, Director
- DELUCCIA ROBERT J, Director
- LUCI DAVID P, President and CEO